KRMD (KORU Medical Systems) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KRMD KORU Medical Systems Inc KRMD
80 GF Score
Price $3.83
GF Value $4.11
Valuation Fairly Valued
View Full Analysis

What is KORU Medical Systems FFO per Share?

FFO per Share only applies to REITs.

KRMD
80GF Score
KORU Medical Systems Inc KRMD
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is KORU Medical Systems (KRMD) Overvalued in 2026?

Based on GuruFocus' analysis, KORU Medical Systems stock appears to be undervalued. The current stock price of $3.83 is trading 6.9% below its estimated GF Value™ of $4.11. GuruFocus considers KORU Medical Systems to be Fairly Valued.

Key valuation signals for KRMD:

  • FFO per Share:
  • GF Value™: $4.11 vs. price of $3.83 (6.9% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KORU Medical Systems Business Description

Address 100 Corporate Drive, Mahwah, NJ, USA, 07430
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
80GF Score

Get the complete analysis for KRMD

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.83
Price
$4.11
GF Value